A study has highlighted the need to convince more women to take part in clinical trials.
One third of women taking part in a recent study into treatments for HIV infections dropped out before the end of the trial, compared with just one-fourth of the men.
Researchers said there was a need for more women to take part in such studies right to the end so that the effectiveness of drugs in development, or already on the market, could be correctly measured.
The GRACE (Gender, Race and Clinical Experience) study found no difference in how each sex reacted to anti-HIV drugs darunavir and ritonavior.
Judith Currier of UCLA said: “It is critical that women are involved in clinical trials to evaluate the efficacy and toxicity of new treatment – not just for HIV but for all diseases.”
The findings were published in the journal Annals of Internal Medicine.
Copyright Press Association 2010